Invention Grant
- Patent Title: Ophthalmic gel and preparation method thereof
-
Application No.: US16539211Application Date: 2019-08-13
-
Publication No.: US11191718B2Publication Date: 2021-12-07
- Inventor: Ming-Cheng Chang , Tsai-Yueh Luo , Cheng-Liang Peng , Kuan-Yin Chen
- Applicant: Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C.
- Applicant Address: TW Taoyuan
- Assignee: Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C.
- Current Assignee: Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C.
- Current Assignee Address: TW Taoyuan
- Agency: Locke Lord LLP
- Agent Tim Tingkang Xia, Esq.
- Priority: TW108115254 20190502
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/06 ; A61K9/127 ; A61K9/107 ; A61K31/165 ; A61K47/36 ; A61K47/42 ; A61K47/12

Abstract:
The present invention provides an ophthalmic gel and a preparation method thereof. The ophthalmic gel comprises: an antibiotic; a nanocarrier, wherein the nanocarrier is used to load the antibiotic; and a biodegradable matrix, wherein the biodegradable matrix is compatible with the nanocarrier to carry the nanocarrier. When the ophthalmic gel of the present invention is applied to the surface of the cornea and conjunctiva of the eyes, the biodegradable matrix is automatically degraded and the nanocarrier carried by the biodegradable matrix will slowly release the antibiotic, loaded in the nanocarrier, at an appropriate rate to overcome the high-frequency use of general ophthalmic drugs and easily caused blurred vision; the present invention further comprises an ophthalmic gel preparation method.
Public/Granted literature
- US20200345631A1 NOVEL OPHTHALMIC GEL AND PREPARATION METHOD THEREOF Public/Granted day:2020-11-05
Information query